MAD-ID 2021


Note: the learning objectives listed below are those for the 2020 Annual Meeting which was cancelled due to the COVID-19 pandemic and associated public heath concerns. As most of the intended content for the 2020 Meeting is being moved to the 2021 Meeting, those objectives are anticipated to be very similar to those below. These objectives will be updated here when the 2021 agenda is finalized in the fall of 2020.

As an attendee of MAD-ID 2021, you will be able to earn up to 18 Continuing Pharmacy (1.8 CEU) or Medical Education hours. MAD-ID is in the process of arranging for CNE.

At the conclusion of this activity, you should be able to:

Depending on which four classroom/workshop sessions the participant attends, four of the following eight learning objectives should be achieved:

  1. Discuss best practices and list EMR tools useful in implementing and monitoring stewardship initiatives and provide an example of how you would utilize one at your practice site
  2. List those beta-lactam antibiotics for which dosing can be optimized based on pharmacodynamic indices and justify the subsequent dosing practices
  3. State the causes, prevalence and consequences of burnout in ID healthcare professions and propose methods for prevention and mitigation
  4. Describe the guidance for assembly and dissemination of antibiograms and how they may be used in formulary and therapeutic decision making in your practice
  5. Outline challenges to implementing antimicrobial stewardship in various healthcare settings and propose two or more approaches to accessing stewardship expertise
  6. Describe methods and provide examples of the application of in vitro susceptibility and pharmacodynamic data to clinical practice with one or more examples relevant to your practice
  7. List and provide rationales for the initiation of antimicrobial stewardship in the outpatient environment at your practice site
  8. Identify methods for the collection and reporting of antimicrobial use metrics in various care settings apropos to your institution

The following learning objective relate to the remaining educational sessions:

  1. Describe the scientific origins of pharmacodyamics as they apply to antimicrobial use and outline current areas of need for further research
  2. Outline the various pros and cons of employing combination therapy in the treatment of Staphylococcus aureus and Gram-negative infections and describe clinical scenarios in which it may be useful
  3. List the major recommendations from the recently revised sepsis guidelines and describe how they will change your or your practice site’s clinical practice(s)
  4. List newer or improved vaccines and explain why they represent advances and how to inform patients of their importance
  5. Explain nuances to antimicrobial stewardship in special populations and propose methods for their application in pediatric and cystic fibrosis patients
  6. Describe how recent changes in epidemiology and management of HIV have altered practices in your healthcare environment
  7. List the major recommendations from the recently revised guidelines for asymptomatic bacteriuria and community-acquired pneumonia and describe how they will change your or your practice site’s clinical practice(s)
  8. Describe the microbiology, epidemiology and relevant pathophysiology of Candida auris and non-tubercular mycobacterial infections and propose stewardship measures that may be helpful in them
  9. Describe at least two significant findings that were presented at one of the recent national or international infectious diseases meetings and explain how they might affect stewardship practices at your practice site of institution